Rana McKay
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Rana McKay
May 25, 2024, 07:09 |
Societies
Neeraj Agarwal summarizes some Abstracts of ASCO24
Neeraj Agarwal shared on X: Abstract #5010 by Michael Morris Phase 1 study of Actinium-225-labeled…
May 23, 2024, 00:35 |
Drugs
Toni Choueiri: The story of adaptive IO therapy in RCC
Toni Choueiri recently shared a post by Rana McKay, an Associate Professor of Medicine at…
May 20, 2024, 14:52 |
Blog
Rana McKay: A legacy
Rana McKay, Associate Professor of Medicine at UC San Diego, shared on X/Twitter: "My heart is…
Apr 29, 2024, 22:41 |
Blog
Rana McKay: Critical Paper Validates Surrogacy of cPFS and rPFS in mHSPC
Rana McKay, Associate Professor of Medicine at UC San Diego, shared on their X/Twitter: ''Very important…
Apr 28, 2024, 10:46 |
Insight
Sumanta Pal: Kicking off our Southern California Regional Collaborative journal club
Sumanta Pal, Head of the Kidney and Bladder Cancer Disease at City of Hope Medical…
Apr 26, 2024, 19:38 |
Opinion
Pedro C Barata: Our work on transcriptomic profiles in RCC
Pedro C Barata, Medical Oncologist at University Hospitals Seidman Cancer Center, posted on X/Twitter: "Happy…
Apr 21, 2024, 08:54 |
Insight
Rana McKay wins the 2024 Christopher G. Wood Rising Star Award at IKCS Europe
Rana McKay won the 2024 Christopher G. Wood Rising Star Award at IKCS Europe, which…
Apr 21, 2024, 07:20 |
Blog
Rana McKay: UroOnco24 meeting in São Paulo
Rana McKay, GU Medical Oncologist at UC San Diego, shared on X: "At the UroOnco24…
Apr 18, 2024, 10:00 |
Insight
Denis Jardim: Our meta-analysis concerns on neo-adjuvant intensified androgen deprivation in prostate cancer
Denis Jardim, Chief of GU Cancer at Grupo Oncoclínicas, made the following post on X:…
Apr 15, 2024, 12:07 |
Blog
Neeraj Agarwal: A comprehensive review of PARPi+ARPI combos in 1st line mCRPC
Neeraj Agarwal shared a post on X: "Just in A comprehensive review of PARPi+ARPI combos…
1
2
All:
20
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube